[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Soleno Therapeutics Inc 100 MARINE PARKWAY SUITE 400 REDWOOD CITY CA 94065 USA

www.soleno.life Employees: 182 P: 650-213-8444 F: 650-213-8383

Sector:

Medical

Description:

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 2,762,881
Enterprise Value, $K 2,742,631
Shares Outstanding, K 52,120
Float, K 48,784
% Float 93.60%
Short Interest, K 5,800
Short Float 11.13%
Days to Cover 1.00
Short Volume Ratio 0.31
% of Insider Shareholders 6.40%
% of Institutional Shareholders 97.42%

Financials:

Annual Sales, $ 190,410 K
Annual Net Income, $ 20,890 K
Last Quarter Sales, $ 94,600 K
Last Quarter Net Income, $ 31,380 K
EBIT, $ 86,450 K
EBITDA, $ 88,500 K

Growth:

1-Year Return -29.39%
3-Year Return 995.25%
5-Year Return 243.11%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 106.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.59 on 05/07/26
Next Earnings Date 08/05/26
Earnings Per Share ttm 1.18
EPS Growth vs. Prev Qtr -26.25%
EPS Growth vs. Prev Year 162.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/26/22

SLNO Ratios

Ratio
Price/Earnings ttm 29.94
Price/Earnings forward 14.46
Price/Earnings to Growth N/A
Return-on-Equity % 22.86%
Return-on-Assets % 18.26%
Profit Margin % 10.97%
Debt/Equity 0.10
Price/Sales 14.51
Price/Cash Flow 124.06
Price/Book 5.57
Book Value/Share 9.51
Interest Coverage 4.81
60-Month Beta -2.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.